Previous 10 | Next 10 |
Industry veteran brings extensive experience leading business development groups Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology , toda...
I track stocks with the highest short interest because the list often times presents good candidates for contrarian type investments ideas given the potential for significant mispricing situations. One example would be a stock with a large short interest going into an earnings release that cou...
The following slide deck was published by Anika Therapeutics, Inc. in conjunction with this Read more ...
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology , today announced plans to showcase HYALOFAST, a biodegradable, HA-based scaffold for cartila...
The trade war with China and the potential for a slowing U.S. economy have provided a unique investment opportunity for domestic small-cap companies. We have written about six unique investment opportunities that have great potential in 2019. These companies are both growth and value oriented ...
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology , today announced plans to showcase its regenerative medicine and orthobiologics portfolio at...
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology , today announced that the Company will participate in the following two investor events in M...
Biogen ( BIIB ) - The company announced interim results from a phase 1/2 study of tofersen (antisense oligonucleotide) being studied for the treatment of amyotrophic lateral sclerosis ((ALS)). Data was sufficiently encouraging to support initiation of phase 3 study in SOD1-ALS patients and ...
The following slide deck was published by Anika Therapeutics, Inc. in conjunction with their 2019 Q1 earnings Read more ...
Anika Therapeutics, Inc. (ANIK) Q1 2019 Earnings Conference Call May 2, 2019 5:00 PM ET Company Participants Sylvia Cheung – Chief Financial Officer Joseph Darling – President and Chief Executive Officer Conference Call Participants Mike Petusky – Barring...
News, Short Squeeze, Breakout and More Instantly...
Anika Therapeutics Inc. Company Name:
ANIK Stock Symbol:
NASDAQ Market:
Anika Therapeutics Inc. Website:
Integrity and its complete arthroscopic instrumentation platform are now fully available in the U.S., expanding Anika’s proprietary hyaluronic acid (HA) regenerative portfolio Over 300 surgeries completed during the limited market release, highlighting the growing interest and commerci...
2024-07-09 17:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-29 13:30:02 ET Stephens analyst issues EQUAL-WEIGHT recommendation for ANIK on May 29, 2024 12:00PM ET. The previous analyst recommendation was Equal-Weight. ANIK was trading at $25.32 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...